ENALAPRIL (MK-421), A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - ACUTE AND CHRONIC EFFECTS IN HEART-FAILURE

被引：20

作者：

DUNKMAN, WB

WILEN, M

FRANCIOSA, JA

机构：

[1] VET ADM MED CTR,CARDIOVASC SECT,PHILADELPHIA,PA 19104

[2] HOSP UNIV PENN,PHILADELPHIA,PA 19104

来源：

CHEST | 1983年 / 84卷 / 05期

关键词：

D O I：

10.1378/chest.84.5.539

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：539 / 545

页数：7

共 50 条

[21] TREATMENT OF CHRONIC HEART-FAILURE WITH ANGIOTENSIN CONVERTING ENZYME-INHIBITOR
SCHOFER, J
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (43) : 1684 - 1689
[22] ANGIOTENSIN CONVERTING ENZYME (ACE) INDUCTION IN THE RAT BY ENALAPRIL (MK-421)
JACKSON, B
CUBELA, R
JOHNSTON, CI
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (04) : 436 - 436
[23] CONCOMITANT BLOCKADE AND ACTIVATION OF THE RENIN-ALDOSTERONE SYSTEM BY AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR (MK-421) AND HYDROCHLOROTHIAZIDE
GRIFFING, GT
MELBY, JC
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 32 (03): : 396 - 405
[24] ENALAPRIL, A NONSULFHYDRYL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
VLASSES, PH
LARIJANI, GE
CONNER, DP
FERGUSON, RK
CLINICAL PHARMACY, 1985, 4 (01): : 27 - 40
[25] EFFECT OF THE ANGIOTENSIN-I CONVERTING ENZYME-INHIBITOR, MK-421, ON EXPERIMENTALLY INDUCED DRINKING
FREGLY, MJ
FATER, DC
GREENLEAF, JE
APPETITE, 1982, 3 (04) : 309 - 319
[26] BENEFICIAL HEMODYNAMIC EFFECTS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CHRONIC REFRACTORY HEART-FAILURE
ADER, R
CHATTERJEE, K
PORTS, T
HIRAMATSU, B
PARMLEY, W
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 43 (02): : 404 - 404
[27] EFFECTS OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, ENALAPRIL, IN ACUTE AND CHRONIC LEFT-VENTRICULAR FAILURE IN DOGS
LEDDY, CL
WILEN, M
FRANCIOSA, JA
JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (5-6): : 189 - 198
[28] EFFECT OF THE CONVERTING ENZYME-INHIBITOR (CEI) MK-421 ON ISCHEMIC ACUTE-RENAL-FAILURE (ARF) IN THE RAT
KOELZ, AM
BRUNNER, FP
WUNDERLICH, P
THIEL, GT
KIDNEY INTERNATIONAL, 1983, 23 (06) : 902 - 902
[29] HYPERTENSIVE CRISIS IN SYSTEMIC-SCLEROSIS - TREATMENT WITH THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 (ENALAPRIL) IN CAPTOPRIL-INTOLERANT PATIENTS
SMITH, CD
SMITH, RD
KORN, JH
ARTHRITIS AND RHEUMATISM, 1984, 27 (07): : 826 - 828
[30] EVIDENCE FOR A VASODEPRESSOR EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, MK421 (ENALAPRIL), INDEPENDENT OF BLOCKADE OF ANGIOTENSIN-II FORMATION
WILKES, BM
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (06) : 1036 - 1042

← 1 2 3 4 5 →